fundvisualizer.com

Matthews Asia Total Return Bond InvestorMAINX

Performance (before sales charge)

As of 08/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 06/30/2022
Stock
0.00%
Non-U.S. Stock
0.00%
Bond
0.00%
Non-U.S. Bond
65.36%
Preferred
0.00%
Convertible
25.36%
Cash
9.28%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 06/30/2022

Basic materials

0.00%

Consumer cyclical

0.00%

Financial services

0.00%

Real estate

0.00%

Consumer defensive

0.00%

Health care

0.00%

Utilities

0.00%

Communication services

0.00%

Energy

0.00%

Industrials

0.00%

Technology

0.00%

Top 10 holdings

As of 06/30/2022

Us Dollar
9.25%
China Development Bank 3.8%
6.55%
FRANSHION BRILLIANT LTD
6.13%
Wanda Properties International Co Ltd. 7.25%
5.43%
ESR Group Limited 5.65%
5.21%
Krw/Usd Fwd 20221222 161
5.17%
Usd/Krw Fwd 20221222 161
5.15%
Usd/Cny Fwd 20221222 161
5.06%
Cny/Usd Fwd 20221222 161
5.05%
Luye Pharma Group Ltd. 1.5%
4.84%
Fund assets

$61.01 Million

Share class

Inv

Morningstar category

Emerging Markets Bond

Expense ratio

1.05%

Investment objective

Income

Documents